Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionSeacrest Wealth Management, Llc
Latest Disclosed Ownership14,480 shares
Latest Disclosed Value $ 5,094,791
Seacrest Wealth Management, Llc reports 1.16% increase in ownership of AMGN / Amgen Inc.

On April 15, 2026 - Seacrest Wealth Management, Llc filed a 13F-HR form disclosing ownership of 14,480 shares of Amgen Inc. (MX:AMGN) valued at $5,094,791 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 14,314 shares of Amgen Inc.. This represents a change in shares of 1.16% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F AMGEN COM 031162100 14,480 166 1.16 5,095 4.17 0.5449
2026-01-12 2025-12-31 13F AMGEN COM 031162100 14,314 -270 -1.85 4,890 13.83 0.4949
2025-11-13 2025-09-30 13F AMGEN COM 031162100 14,584 -630 -4.14 4,297 1.15 0.4533
2025-07-11 2025-06-30 13F AMGEN COM 031162100 15,214 -647 -4.08 4,248 -14.05 0.4613
2025-04-11 2025-03-31 13F AMGEN COM 031162100 15,861 -437 -2.68 4,942 16.34 0.5594
2025-01-14 2024-12-31 13F AMGEN COM 031162100 16,298 -3,085 -15.92 4,248 -31.99 0.4466
2024-10-16 2024-09-30 13F AMGEN COM 031162100 19,383 114 0.59 6,245 3.74 0.6726
2024-07-22 2024-06-30 13F AMGEN COM 031162100 19,269 2,598 15.58 6,021 27.00 0.6851
2024-04-18 2024-03-31 13F AMGEN COM 031162100 16,671 -212 -1.26 4,740 -7.33 0.5795
2024-01-18 2023-12-31 13F AMGEN COM 031162100 16,883 -88 -0.52 5,116 12.15 0.6318
2023-10-12 2023-09-30 13F AMGEN COM 031162100 16,971 -282 -1.63 4,561 19.09 0.5925
2023-07-14 2023-06-30 13F AMGEN COM 031162100 17,253 -515 -2.90 3,830 -10.83 0.4836
2023-05-12 2023-03-31 13F AMGEN COM 031162100 17,768 246 1.40 4,295 -6.65 0.5818
2023-02-14 2022-12-31 13F AMGEN COM 031162100 17,522 -62 -0.35 4,602 16.10 0.6601
2022-11-15 2022-09-30 13F AMGEN COM 031162100 17,584 357 2.07 3,963 -5.44 0.6015
2022-08-09 2022-06-30 13F AMGEN COM 031162100 17,227 -70 -0.40 4,191 0.19 0.5275
2022-05-16 2022-03-31 13F AMGEN COM 031162100 17,297 123 0.72 4,183 8.26 0.4804
2022-02-11 2021-12-31 13F AMGEN COM 031162100 17,174 -4,075 -19.18 3,864 -14.49 0.4238
2021-11-16 2021-09-30 13F AMGEN COM 031162100 21,249 -333 -1.54 4,519 -14.09 0.5451
2021-08-12 2021-06-30 13F AMGEN COM 031162100 21,582 168 0.78 5,260 -1.28 0.6343
2021-05-17 2021-03-31 13F AMGEN COM 031162100 21,414 1,202 5.95 5,328 14.65 0.7055
2021-02-09 2020-12-31 13F AMGEN COM 031162100 20,212 253 1.27 4,647 -8.40 0.6534
2020-11-12 2020-09-30 13F AMGEN COM 031162100 19,959 187 0.95 5,073 8.77 0.8130
2020-07-27 2020-06-30 13F AMGEN COM 031162100 19,772 153 0.78 4,664 17.27 0.8061
2020-05-13 2020-03-31 13F AMGEN COM 031162100 19,619 542 2.84 3,977 -13.52 0.8548
2020-01-22 2019-12-31 13F AMGEN COM 031162100 19,077 269 1.43 4,599 26.35 0.7706
2019-10-15 2019-09-30 13F AMGEN COM 031162100 18,808 9,729 107.16 3,640 117.57 0.6814
2019-07-19 2019-06-30 13F AMGEN COM 031162100 9,079 305 3.48 1,673 0.36 0.3406
2019-05-10 2019-03-31 13F AMGEN COM 031162100 8,774 227 2.66 1,667 0.18 0.2860
2019-02-13 2018-12-31 13F AMGEN COM 031162100 8,547 -473 -5.24 1,664 -11.02 0.3430
2018-11-14 2018-09-30 13F AMGEN COM 031162100 9,020 147 1.66 1,870 14.16 0.3164
2018-08-03 2018-06-30 13F AMGEN COM 031162100 8,873 -251 -2.75 1,638 5.34 0.2951
2018-04-20 2018-03-31 13F AMGEN COM 031162100 9,124 -106 -1.15 1,555 -3.12 0.2852
2018-02-02 2017-12-31 13F AMGEN COM 031162100 9,230 9,230 1,605 0.2935
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.